Literature DB >> 7525713

Regulation of monocyte integrin expression by beta-family chemokines.

K Vaddi1, R C Newton.   

Abstract

In the present study we investigated the ability of three monocyte chemokines (MCP-1, MIP-1 alpha, and RANTES) to modulate monocyte adhesion molecules in an attempt to evaluate their potential to induce tissue infiltration of macrophages in vivo. All three chemokines tested induced increased expression of the alpha-chains of two members of beta 2 family of integrins, CD11b and CD11c, and their common beta-chain (CD18). They had no effect on CD11a expression. Enhancement of CD11b and CD11c was dose dependent and followed a distinct time course with peak levels at 4 h. Levels declined to reach basal levels by 24 h. In contrast, IL-1 induced enhancement remained high after 24 h of stimulation. However, the increases caused by chemokines were not mediated by IL-1 as indicated by lack of inhibition by the IL-1R antagonist. Studies on the mechanism of integrin up-regulation showed that mobilization of cytosolic free calcium is an important signaling event in this response and that up-regulation is associated with mobilization from intracellular pools mediated by microtubules. Enhanced CD11b and CD11c expression by chemokines was also found to result in enhancement of monocyte binding to endothelial cells. Further studies indicated that monocyte binding to endothelial cells follows similar dose-response kinetics as the up-regulation of integrins and can be partially blocked by Abs to CD11b and CD11c. These results suggest that modulation of the integrin expression by chemokines may facilitate the tissue trafficking of monocytes during inflammation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525713

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  The transcriptional responses of respiratory epithelial cells to Bordetella pertussis reveal host defensive and pathogen counter-defensive strategies.

Authors:  C E Belcher; J Drenkow; B Kehoe; T R Gingeras; N McNamara; H Lemjabbar; C Basbaum; D A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  RelB regulation of chemokine expression modulates local inflammation.

Authors:  Y Xia; M E Pauza; L Feng; D Lo
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

3.  The peptide of sequence 66-77 of monocytic chemotactic protein (MCP-1) inhibits inflammation in experimental animals.

Authors:  T L Krasnikova; T I Arefieva; M G Melekhov; N B Kukhtina; M V Sidorova; A S Molokoedov; V N Bushuev; Zh D Bespalova; E I Chazov
Journal:  Dokl Biol Sci       Date:  2005 Sep-Oct

4.  Maternal and fetal intrauterine tissue crosstalk promotes proinflammatory amplification and uterine transition†.

Authors:  Kelycia B Leimert; Angela Messer; Theora Gray; Xin Fang; Sylvain Chemtob; David M Olson
Journal:  Biol Reprod       Date:  2019-03-01       Impact factor: 4.285

5.  Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease.

Authors:  S J Choi; Y Oba; Y Gazitt; M Alsina; J Cruz; J Anderson; G D Roodman
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

6.  Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting.

Authors:  T I Arefieva; T L Krasnikova; A V Potekhina; N U Ruleva; P I Nikitin; T I Ksenevich; B G Gorshkov; M V Sidorova; Zh D Bespalova; N B Kukhtina; S I Provatorov; E A Noeva; E I Chazov
Journal:  Inflamm Res       Date:  2011-07-10       Impact factor: 4.575

Review 7.  Chemokines and tissue injury.

Authors:  M B Furie; G J Randolph
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

8.  Novel ex vivo culture method for human monocytes uses shear flow to prevent total loss of transendothelial diapedesis function.

Authors:  Yoshiaki Tsubota; Jeremy M Frey; Elaine W Raines
Journal:  J Leukoc Biol       Date:  2013-09-04       Impact factor: 4.962

9.  The GPR55 antagonist CID16020046 protects against intestinal inflammation.

Authors:  A Stančić; K Jandl; C Hasenöhrl; F Reichmann; G Marsche; R Schuligoi; A Heinemann; M Storr; R Schicho
Journal:  Neurogastroenterol Motil       Date:  2015-07-30       Impact factor: 3.598

10.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.